Israel to India: Vati Import Trade Route

The Israel to India Vati corridor is one of India's established pharmaceutical import routes from Israel, with 25 shipments documented worth a combined $14.6K USD. The route is dominated by TEVA PHARMACEUTICAL INDUSTRIES LTD , which alone accounts for roughly 79% of all import value, reflecting the consolidated nature of Israel's vati export sector.

Across 3 active Israel suppliers, the average shipment value stands at $585 USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 79% of all shipments, consistent with vati's non-urgent bulk-order profile.

Shipment activity peaks during April–June, with an average transit time of 21 days port-to-port. The route has recorded an annual growth rate of 24.3%, placing it at rank #10 among India's top vati import origins globally.

On the Indian buyer side, key Indian importers include WATSON PHARMA PRIVATE LIMITED , LOTUS LABS PRIVATE LIMITED , WATSON PHARMA PRIVATE LIMITED. WATSON PHARMA PRIVATE LIMITED is the single largest Indian importer with 3 shipments valued at $11.6K USD.

India's vati imports from Israel are driven primarily by a handful of large-scale Israel manufacturers. TEVA PHARMACEUTICAL INDUSTRIES LTD with 3 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 3 active exporters signals a competitive but concentrated market — Indian buyers benefit from Israel supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — TEVA PHARMACEUTICAL INDUSTRIES LTD , TEVA PHARMACEUTICAL INDUSTRIES LTD. , TEVA PHARMACEUTICAL INDUSTRIES LTD — together account for 100% of total trade value on this route. The average shipment value of $585 USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as (foc) test product (t1): lenvatinib 10 mg capsules 10 milligram (mg) 120 capsules (2 bottles) usd and (foc) test product (t2): lenvatinib 10 mg capsules 10 milligram (mg) 120 capsules (2 bottles) usd , suggesting that Indian buyers tend to consolidate orders across related product lines from the same Israel supplier.

On the buying side, WATSON PHARMA PRIVATE LIMITED is the largest importer with 3 shipments worth $11.6K USD — representing 79% of all vati imports from Israel on this route.